Heptavalent Pneumococcal Conjugate Vaccine

3 trials

Sponsors

Finlay Institute Vaccine, Instituto Finlay de Vacunas (IFV), Finlay Vaccine Institute (FVI)

Conditions

Pneumococcal diseasePneumococcal diseases VCN7-TPneumococcal infections, invasive pneumococcal disease and related syndromes

Phase 2

Safety and immunogenicity of VCN7-T in infants of 2 and 3 months. Phase I/II.

Active, not recruitingRPCEC00000243

Finlay Institute VaccinePneumococcal disease

Start: 2017-05-24Target: 880Updated: 2026-09-14

Phase 3

Phase III study of the Cuban vaccine candidate VCN7-T in patients from 1 to 18 years of age at risk of pneumococcal disease in Havana

Active, not recruitingRPCEC00000432

Finlay Vaccine Institute (FVI)Pneumococcal diseases VCN7-T

Start: 2023-10-09Updated: 2026-09-14

Unknown Phase

Study on pneunococcal vaccination in the pediatric population from 1 year to 5 years

Active, not recruitingRPCEC00000428

Instituto Finlay de Vacunas (IFV)Pneumococcal infections, invasive pneumococcal disease and related syndromes

Start: 2023-09-18Target: 18771Updated: 2026-09-14